Physician

Chirag P Shah, MD

According to 2025 Medicare claims, Chirag Shah, MD (NPI: 1487872412) practices ophthalmology in the Cambridge-Newton-Framingham, MA market, with the plurality of this provider's patient population coming from Middlesex, MA. This provider's primary affiliated billing organization is OPHTHALMIC CONSULTANTS OF BOSTON, INC. (NPI: 1932146594; TIN: 04-2500346) and primary practice location at 02451-1111. Shah is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641), participating under the MSSP model.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,582 traditional Medicare patients, billed 64,092 HCPCS/CPT codes, and received $6,300,704 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 1,010 prescription claims across 301 beneficiaries totaling $64,889 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 5 records totaling $235,863. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $2,048,990 to $6,300,704. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $34,535 and ending at $64,889. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.2M$6.3M2015 Medicare payment: $2,048,990 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,357,812 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,717,277 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,211,828 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,664,610 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,769,227 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,894,903 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,460,802 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $5,052,046 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $6,300,704 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,76712,408$2,048,990
20162,06215,085$2,357,812
20172,19016,589$2,717,277
20182,29017,819$3,211,828
20192,35319,116$3,664,610
20202,15117,565$3,769,227
20212,61122,568$4,894,903
20222,49622,743$4,460,802
20232,62240,048$5,052,046
20242,58264,092$6,300,704

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$43K$86K2015 Drug cost: $34,535 (USD; Tot_Drug_Cst)2016 Drug cost: $38,211 (USD; Tot_Drug_Cst)2017 Drug cost: $84,566 (USD; Tot_Drug_Cst)2018 Drug cost: $66,724 (USD; Tot_Drug_Cst)2019 Drug cost: $70,996 (USD; Tot_Drug_Cst)2020 Drug cost: $69,221 (USD; Tot_Drug_Cst)2021 Drug cost: $85,888 (USD; Tot_Drug_Cst)2022 Drug cost: $71,411 (USD; Tot_Drug_Cst)2023 Drug cost: $67,330 (USD; Tot_Drug_Cst)2024 Drug cost: $64,889 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015150492$34,535
2016217647$38,211
2017231762$84,566
2018229840$66,724
2019233732$70,996
2020237751$69,221
2021243839$85,888
2022281870$71,411
2023321933$67,330
20243011,010$64,889

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg3143,046$661
67028Injection of drug into eye6243,337$104
92014Established patient complete exam of visual system2,3243,236$98
92012Established patient problem focused exam of visual system328436$73
92134Imaging of retina2,4425,945$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate28510,811$11,097
Bromfenac SodiumBromfenac Sodium531,930$10,520
Restasis MultidoseCyclosporine14394$9,124
DifluprednateDifluprednate301,103$3,259
Ketorolac TromethamineKetorolac Tromethamine662,979$1,284

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$5,751Regeneron Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.1$230,112EyePoint Pharmaceuticals US, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Chirag P. Shah, MD?

Tedicare shows public-source Medicare data for Chirag P. Shah, MD (NPI 1487872412), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chirag P. Shah, MD have ACO affiliation data?

Chirag P. Shah, MD is shown with ACO affiliation data for Mass General Brigham ACO, LLC (MSSP, ACO ID A4641).

What billing organization is linked to Chirag P. Shah, MD?

Chirag P. Shah, MD is linked to OPHTHALMIC CONSULTANTS OF BOSTON, INC. (billing NPI 1932146594) in the available physician profile data.

Does Chirag P. Shah, MD have Open Payments data?

Chirag P. Shah, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.